Eisai Co., Ltd. (4523.T)
JPY 3888.0
(0.6%)
JPY 3888.0
(0.6%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 494.82 Billion JPY | 12.26% |
| 2022 | 440.77 Billion JPY | -5.77% |
| 2021 | 467.78 Billion JPY | 29.2% |
| 2020 | 362.06 Billion JPY | 0.71% |
| 2019 | 359.51 Billion JPY | -14.31% |
| 2018 | 419.53 Billion JPY | -3.54% |
| 2017 | 434.93 Billion JPY | 1.58% |
| 2016 | 428.17 Billion JPY | 7.81% |
| 2015 | 397.15 Billion JPY | -12.09% |
| 2014 | 451.75 Billion JPY | 3.96% |
| 2013 | 434.55 Billion JPY | -15.77% |
| 2012 | 515.94 Billion JPY | -11.23% |
| 2011 | 581.23 Billion JPY | -8.6% |
| 2010 | 635.92 Billion JPY | -6.51% |
| 2009 | 680.17 Billion JPY | -4.89% |
| 2008 | 715.11 Billion JPY | 6.71% |
| 2007 | 670.14 Billion JPY | 192.11% |
| 2006 | 229.41 Billion JPY | 0.61% |
| 2005 | 228.01 Billion JPY | 12.27% |
| 2004 | 203.1 Billion JPY | 3.46% |
| 2003 | 196.31 Billion JPY | 1.12% |
| 2002 | 194.14 Billion JPY | -0.72% |
| 2001 | 195.54 Billion JPY | 0.59% |
| 2000 | 194.4 Billion JPY | 32.45% |
| 1999 | 146.77 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 500.55 Billion JPY | 1.16% |
| 2023 Q4 | 494.82 Billion JPY | 5.61% |
| 2023 Q1 | 437.43 Billion JPY | -0.76% |
| 2023 FY | 494.82 Billion JPY | 12.26% |
| 2023 Q2 | 449.14 Billion JPY | 2.68% |
| 2023 Q3 | 468.51 Billion JPY | 4.31% |
| 2022 Q2 | 410.57 Billion JPY | -7.64% |
| 2022 FY | 440.77 Billion JPY | -5.77% |
| 2022 Q3 | 453.99 Billion JPY | 10.58% |
| 2022 Q4 | 440.77 Billion JPY | -2.91% |
| 2022 Q1 | 444.52 Billion JPY | -4.97% |
| 2021 Q3 | 408.68 Billion JPY | 6.21% |
| 2021 FY | 467.78 Billion JPY | 29.2% |
| 2021 Q1 | 381.98 Billion JPY | 5.5% |
| 2021 Q4 | 467.78 Billion JPY | 14.46% |
| 2021 Q2 | 384.77 Billion JPY | 0.73% |
| 2020 Q3 | 331.35 Billion JPY | -3.62% |
| 2020 Q2 | 343.79 Billion JPY | 2.02% |
| 2020 FY | 362.06 Billion JPY | 0.71% |
| 2020 Q1 | 336.98 Billion JPY | -6.27% |
| 2020 Q4 | 362.06 Billion JPY | 9.27% |
| 2019 Q1 | 394.08 Billion JPY | -6.07% |
| 2019 Q2 | 376.3 Billion JPY | -4.51% |
| 2019 Q3 | 382.36 Billion JPY | 1.61% |
| 2019 Q4 | 359.51 Billion JPY | -5.98% |
| 2019 FY | 359.51 Billion JPY | -14.31% |
| 2018 Q2 | 426.53 Billion JPY | -4.62% |
| 2018 Q1 | 447.19 Billion JPY | 2.82% |
| 2018 Q3 | 401.68 Billion JPY | -5.82% |
| 2018 FY | 419.53 Billion JPY | -3.54% |
| 2018 Q4 | 419.53 Billion JPY | 4.44% |
| 2017 Q2 | 422.48 Billion JPY | -0.69% |
| 2017 Q4 | 434.93 Billion JPY | -0.53% |
| 2017 FY | 434.93 Billion JPY | 1.58% |
| 2017 Q1 | 425.43 Billion JPY | -0.64% |
| 2017 Q3 | 437.24 Billion JPY | 3.49% |
| 2016 Q1 | 400.36 Billion JPY | 0.81% |
| 2016 FY | 428.17 Billion JPY | 7.81% |
| 2016 Q4 | 428.17 Billion JPY | -0.26% |
| 2016 Q3 | 429.28 Billion JPY | 7.25% |
| 2016 Q2 | 400.26 Billion JPY | -0.02% |
| 2015 FY | 397.15 Billion JPY | -12.09% |
| 2015 Q1 | 402.04 Billion JPY | -11.01% |
| 2015 Q2 | 397.1 Billion JPY | -1.23% |
| 2015 Q3 | 417.6 Billion JPY | 5.16% |
| 2015 Q4 | 397.15 Billion JPY | -4.9% |
| 2014 Q4 | 451.75 Billion JPY | -1.68% |
| 2014 Q2 | 427.33 Billion JPY | -0.89% |
| 2014 Q1 | 431.18 Billion JPY | -0.78% |
| 2014 Q3 | 459.48 Billion JPY | 7.52% |
| 2014 FY | 451.75 Billion JPY | 3.96% |
| 2013 Q1 | 462.08 Billion JPY | -10.44% |
| 2013 FY | 434.55 Billion JPY | -15.77% |
| 2013 Q2 | 457.3 Billion JPY | -1.04% |
| 2013 Q3 | 470.5 Billion JPY | 2.89% |
| 2013 Q4 | 434.55 Billion JPY | -7.64% |
| 2012 FY | 515.94 Billion JPY | -11.23% |
| 2012 Q1 | 577.66 Billion JPY | -0.61% |
| 2012 Q4 | 515.94 Billion JPY | -4.15% |
| 2012 Q3 | 538.26 Billion JPY | 4.35% |
| 2012 Q2 | 515.8 Billion JPY | -10.71% |
| 2011 FY | 581.23 Billion JPY | -8.6% |
| 2011 Q3 | 578.38 Billion JPY | 5.28% |
| 2011 Q1 | 567.23 Billion JPY | -10.8% |
| 2011 Q4 | 581.23 Billion JPY | 0.49% |
| 2011 Q2 | 549.35 Billion JPY | -3.15% |
| 2010 Q1 | 667.39 Billion JPY | -1.88% |
| 2010 FY | 635.92 Billion JPY | -6.51% |
| 2010 Q4 | 635.92 Billion JPY | -2.36% |
| 2010 Q2 | 659.6 Billion JPY | -1.17% |
| 2010 Q3 | 651.29 Billion JPY | -1.26% |
| 2009 Q2 | 686.39 Billion JPY | -1.52% |
| 2009 Q4 | 680.17 Billion JPY | -3.97% |
| 2009 FY | 680.17 Billion JPY | -4.89% |
| 2009 Q3 | 708.25 Billion JPY | 3.18% |
| 2009 Q1 | 696.96 Billion JPY | -2.54% |
| 2008 Q4 | 715.11 Billion JPY | 0.0% |
| 2008 FY | 715.11 Billion JPY | 6.71% |
| 2007 FY | 670.14 Billion JPY | 192.11% |
| 2006 FY | 229.41 Billion JPY | 0.61% |
| 2005 FY | 228.01 Billion JPY | 12.27% |
| 2004 FY | 203.1 Billion JPY | 3.46% |
| 2003 FY | 196.31 Billion JPY | 1.12% |
| 2002 FY | 194.14 Billion JPY | -0.72% |
| 2001 FY | 195.54 Billion JPY | 0.59% |
| 2000 FY | 194.4 Billion JPY | 32.45% |
| 1999 FY | 146.77 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -1880.251% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 93.684% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 34.144% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | -201.073% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -14475.201% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | -1054.299% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -1675.73% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -9717.956% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | -702.063% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -1504.907% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -1143.466% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -1491.896% |
| Tsumura & Co. | 132.88 Billion JPY | -272.368% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -1143.56% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -3621.328% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | -80.095% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | -1020.578% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | -599.846% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | -955.221% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -6965.9% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -1845.143% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -5977.337% |
| MedRx Co., Ltd | 129 Million JPY | -383485.271% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -15020.541% |
| Solasia Pharma K.K. | 673 Million JPY | -73425.26% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -76557.273% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -1476.83% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | -201.734% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -48827.66% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 5.565% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -7017.389% |